Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about BMRN

Recent news which mentions BMRN

< Previous 1 2 3 4 5 6 7 Next >
Jim Cramer Is All Aboard Union Pacific, But Shows No Love For Orphan Drugs
Tickers BMRN GTLB NEWS OKLO
Tags Media GTLB Benzinga
From Benzinga
Here Are All 6 Stocks I've Bought Through 5 Months of 2025
Tickers BMRN FSLY INTC PFE
Tags SIRI PUBM PFE
From Motley Fool
10 Analysts Assess Biomarin Pharmaceutical: What You Need To Know
Tickers BMRN
Tags Benzinga BMRN Analyst Ratings
From Benzinga
A Look Into Biomarin Pharmaceutical Inc's Price Over Earnings
Tickers BMRN NEWS
Tags News BZI/PE Benzinga
From Benzinga
Earnings Scheduled For May 1, 2025
Tickers AAMI AAPL ABNB ACCO
Tags COHN CNR EIG
From Benzinga
Trump's New Order Targets Drug Pricing Transparency And Medicare Cost Reduction
Tickers ABBV AZN BIIB BMRN
Tags BIIB Top Stories Benzinga
From Benzinga
6 Stocks With Clear Price Dislocations That I Purchased During Wall Street's Historic Volatility
Tickers BMRN FSLY INTC PFE
Tags PFE SIRI PUBM
From Motley Fool
BioMarin Seeks Label Expansion For Palynziq After Positive Phase 3 Results In Adolescent Patients
Tickers BMRN NEWS
Tags Biotech Stories That Matter Market News
From Benzinga
5 Historically Cheap Growth Stocks to Buy With Confidence in the Wake of the Nasdaq Correction
Tickers AMZN BMRN GOOG GOOGL
Tags ^IXIC ^GSPC TTD
From Motley Fool
Why BioMarin Pharmaceutical Stock Zoomed Almost 5% Higher Today
Tickers BMRN
Tags Market News BMRN Recent Press Releases
From Motley Fool
Demystifying Biomarin Pharmaceutical: Insights From 8 Analyst Reviews
Tickers BMRN
Tags Analyst Ratings Market News BZI/AAR
From Benzinga
Why Is BioMarin Stock Trading Higher On Thursday?
Tickers ASND BMRN NEWS
Tags Biotech Stories That Matter Earnings
From Benzinga
BioMarin: EPS Surges Past Expectations
Tickers BMRN
Tags Market News Recent Press Releases BMRN
From Motley Fool
Earnings Scheduled For February 19, 2025
Tickers ACVA ADI AGI AHH
Tags BTO SEDG EXAS
From Benzinga
Why Is Rare Disease Focused Ascendis Pharma Stock Trading Higher On Thursday?
Tickers ASND AZN BMRN NEWS
Tags ASND Trading Ideas News
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Tickers ACAD BMRN EBS EXEL
Tags BZI/AUOA Benzinga EBS
From Benzinga
Moderna, GameStop And Snap Are Among Top Large-Cap Losers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio?
Tickers BMRN BNTX FTAI GME
Tags Briefs FTAI BMRN
From Benzinga
Alger Launches Russell Innovation ETF To Capitalize On Emerging Innovators
Tickers BMRN BMY FRTY INVN
Tags INVN Top Stories Benzinga
From Benzinga
10 Magnificent Stocks That Can Make You Richer in 2025
Tickers BABA BMRN FVRR META
Tags NEE Market News BMRN
From Motley Fool
The Latest Analyst Ratings For Biomarin Pharmaceutical
Tickers BMRN
Tags BZI/AAR Analyst Ratings Market News
From Benzinga
The Analyst Landscape: 29 Takes On Biomarin Pharmaceutical
Tickers BMRN
Tags BZI/AAR Market News Analyst Ratings
From Benzinga
Peering Into Biomarin Pharmaceutical's Recent Short Interest
Tickers BMRN
Tags Market News BZI/SHORTHIST BMRN
From Benzinga
CAMP4 Analyst Highlights Rare Disease Platform Potential
Tickers BMRN CAMP NEWS
Tags Top Stories Benzinga Analyst Ratings
From Benzinga
BioMarin's Pipeline Faces Skepticism As Analyst Questions Future Growth
Tickers ASND BMRN NEWS SHL
Tags Briefs Guidance BMRN
From Benzinga
In-Depth Examination Of 29 Analyst Recommendations For Biomarin Pharmaceutical
Tickers BMRN
Tags BZI/AAR Market News Analyst Ratings
From Benzinga
A Look Ahead: Biomarin Pharmaceutical's Earnings Forecast
Tickers BMRN
Tags BZI/EP Market News Earnings
From Benzinga
How Is The Market Feeling About Biomarin Pharmaceutical?
Tickers BMRN
Tags Benzinga Trading Ideas Short Ideas
From Benzinga
Biden Administration Unveils Plan To Provide Generic Drugs for $2 to Medicare Recipients
Tickers AMGN AZN BMRN GILD
Tags News PFE REGN
From Benzinga
Analyst Expectations For Biomarin Pharmaceutical's Future
Tickers BMRN
Tags BMRN Benzinga Analyst Ratings
From Benzinga
BioMarin Stands Firm on 2027 Revenue Target Amid Ascendis Competition, Goldman Sachs Analyst Remains Bullish
Tickers ASND BMRN NEWS
Tags Briefs BMRN Market News
From Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.